Indication: Cytomegalovirus (CMV)

A Phase II, Single-Stage, Single-Arm Investigation of Oral Valganciclovir Therapy in Infants with Asymptomatic Congenital Cytomegalovirus Infection

Sub-indication: Infectious Disease

Drug Study

Principal Investigator: Gary Marshall, M.D.
Norton Children's Infectious Diseases, affiliated with the UofL School of Medicine

Sponsor: NIH

Search our entire site.